[Newsdesk] MSF challenges pneumococcal vaccine patent in India
Pfizer and GSK dominate pneumococcal vaccine manufacturing, but an impending court case in India could pave the way for others, which MSF hopes will drive down costs. Ann Danaiya Usher reports.
Source: The Lancet Infectious Diseases - Category: Infectious Diseases Authors: Ann Danaiya Usher Tags: Newsdesk Source Type: research
More News: India Health | Infectious Diseases | Legislation | Meningitis Vaccine | Pfizer | Pneomococcal Vaccine | Vaccines